126 - Treatment of Challenging Infections

Rapid Fire Moderator(s)

• 

  Rachel Bartash, MD

  Associate Professor
  Infectious Diseases
  Montefiore Medical Center
  Bronx, NY, United States

Presentations:

• 12:15 PM - 12:20 PM US ET

  Effective Durations of Antibiotic Therapy for Stenotrophomonas maltophilia Bloodstream Infections
  

  Rapid Fire Presenter: Christina Guo, MD, MPH (she/her/hers) – Johns Hopkins Bloomberg School of Public Health

  Co-Author: Justin Suero, PharmD – Johns Hopkins Hospital

  Co-Author: Pranita Tamma, MD, MHS – Johns Hopkins University School of Medicine
• 12:20 PM - 12:25 PM US ET

  High Dose Daptomycin Shows Non-Inferior Outcome Compared to Linezolid in Patients with Daptomycin and Vancomycin Resistant Enterocci Bloodstream Infection
  

  Rapid Fire Presenter: Wei-Ting Lin, MD – National Taiwan University Hospital

  Co-Author: YuChung Chuang, MD PhD (he/him/his) – National Taiwan University Hospital

  Co-Author: Jann-Tay Wang, MD, PhD – Division of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

  Co-Author: Shan-Chwen Chang, MD, PhD – Division of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
• 12:25 PM - 12:30 PM US ET

  Clinical Outcomes of Ertapenem in Critically Ill Patients with Bacteremia Caused by ESBL-Producing Organisms: A Comparison of Normal/elevated and Low Albumin Levels
  

  Rapid Fire Presenter: Brian Chung, PharmD – Long Island Jewish Medical Center

  Co-Author: Barbara Kamel, PharmD – Long Island Jewish Medical Center

  Co-Author: Kirby An, PharmD (he/him/his) – Long Island Jewish Medical Center/North Shore University Hospital

  Co-Author: Henry Donaghy, MD – Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dayton and Karen Brown Division of Infectious Diseases

  Co-Author: Juby Roy, DO – Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dayton and Karen Brown Division of Infectious Diseases

  Co-Author: Reshma George, DO – Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dayton and Karen Brown Division of Infectious Diseases

  Co-Author: Aya Haghamad, PharmD – Northwell

  Co-Author: Thien-Ly Doan, PharmD – Long Island Jewish Medical Center
• 12:30 PM - 12:35 PM US ET

  Fosmanogepix Expanded Access Experience in Patients With Invasive Aspergillosis
  

  Rapid Fire Presenter: Jana K. Dickter, MD (she/her/hers) – City of Hope National Medical Center

  Co-Author: Alfredo Puing, MD – Yale School of Medicine

  Co-Author: Ana Fernández Cruz, MD, PhD – Hospital Universitario Puerta de Hierro-Majadahonda

  Co-Author: Jannik Stemler, MD – University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I for Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, NRW, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, NRW, Germany

  Co-Author: Apurva Amit Akkad, MD – Keck School of Medicine of the University of Southern California

  Co-Author: Juergen Prattes, MD (he/him/his) – Medical University of Graz

  Co-Author: Ana Belkin, MD – Sheba Medical Center

  Co-Author: Julie M. Steinbrink, MD, MHS – Duke University Medical Center

  Co-Author: Omer E. Beaird, MD (he/him/his) – University of California Los Angeles

  Co-Author: Haran Schlamm, MD – HTS Pharma

  Co-Author: Sanjeet S. Dadwal, MD (he/him/his) – City of Hope National Medical Center

  Co-Author: Luis Ostrosky-Zeichner, MD (he/him/his) – University of Texas Health Science Center
• 12:35 PM - 12:40 PM US ET

  Fosmanogepix Expanded Access Experience in Patients With Fusarium Infections
  

  Rapid Fire Presenter: Sanjeet S. Dadwal, MD (he/him/his) – City of Hope National Medical Center

  Co-Author: Aliyah Baluch, MD – Moffitt Cancer Center

  Co-Author: Jana K. Dickter, MD (she/her/hers) – City of Hope National Medical Center

  Co-Author: Jessica R. Newman, DO (she/her/hers) – University of Kansas Medical Center

  Co-Author: M Hong Nguyen, MD – University of Pittsburgh Medical Center

  Co-Author: Rachel Weihe, MD – University of Kansas Medical Center

  Co-Author: Joy E. Gibson, MD, PhD (she/her/hers) – Children’s Hospital Los Angeles

  Co-Author: Jannik Stemler, MD – University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I for Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, NRW, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, NRW, Germany

  Co-Author: Haran Schlamm, MD – HTS Pharma

  Co-Author: Luis Ostrosky-Zeichner, MD (he/him/his) – University of Texas Health Science Center
• 12:40 PM - 12:45 PM US ET

  Olorofim for the treatment of Central Nervous System (CNS) invasive fungal infections (IFI) in patients with limited or no treatment options: a sub-analysis of an open-label, single-arm, Phase 2b trial (Study 32; NCT03583164)
  

  Rapid Fire Presenter: Fariba Donovan, MD, PhD – University of Arizona College of Medicine-Tucson

  Co-Author: George R. Thompson, III, MD – University of California Davis Medical Center

  Co-Author: Royce Johnson, MD – Kern Medical Center

  Co-Author: Martin Hoenigl, MD (he/him/his) – Medical University of Graz, Graz, Austria

  Co-Author: Johan A. Maertens, MD PhD – UZ Leuven

  Co-Author: Andrej Spec, M.D., MSCI (he/him/his) – Washington University School of Medicine in St. Louis

  Co-Author: Andrea Deschambeault, PharmD – F2G

  Co-Author: Valerie Ravenna, PharmD – F2G

  Co-Author: Daniela Zinzi, MD (she/her/hers) – F2G

  Co-Author: Omar Fernandez, MD – F2G

  Co-Author: John H. Rex, MD – F2G